GlassScriptPhysician profile
Stephen Paul Lee
NPI 1063415958
$1,678.48
in general payments reported to CMS, 2019-2025
12 companies · $108 in 2025
The $108 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $650 · 2020: $387 · 2021: $83.91 · 2022: $81.98 · 2023: $106 · 2024: $262 · 2025: $108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $476.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $590.84 | 2019-2020 | |
| Sirtex Medical INC | $312.43 | 2019-2020 | |
| Boston Scientific Corporation | $281.37 | 2022-2024 | Embold Fibered, Interlock |
| W. L. Gore & Associates, INC. | $141.03 | 2019-2022 | |
| Surmodics, INC. | $93.41 | 2023-2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Sublime 014 Rx Pta Balloon Dilatation Catheter |
| Medtronic, INC. | $89.17 | 2021-2025 | Concertotm |
| Inari Medical, INC. | $43.70 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Becton, Dickinson and Company | $39.78 | 2024 | Fluency Endovascular Stent Graft |
| Abbott Laboratories | $35.88 | 2022-2025 | Perclose Prostyle |
| Healthtronics Stone Solutions, LLC | $24.07 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.05 | 2025 | Wainua |
| Avenu Medical INC. | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.